Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

59
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
59
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

146
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
146
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

106
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
106
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

54
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
54
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

61
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
61
Pneumonia IV: Management01:28

Pneumonia IV: Management

464
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
464

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

[Perioperative and peri-interventional antibiotic prophylaxis: general and urology-specific recommendations from the German Interdisciplinary S3 guideline].

Urologie (Heidelberg, Germany)·2026
Same author

Clinical presentation of chronic abacterial prostatitis shows no association with TAS2R38 taster status.

Urologia internationalis·2026
Same author

Primary investigation of negative impact on sexual function in patients with chronic prostatitis.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica·2026
Same author

Changing Face of Radical Prostatectomy: A Nationwide Registry Study of Case-Mix, Surgical Evolution, and Outcomes.

Cancers·2026
Same author

Bilateral retrovesical splenosis following childhood splenectomy mimicking pelvic malignancy: A video case report.

Urology case reports·2026
Same author

Pilot Survey about the perspective on Generation Z among European leaders in Urology: Challenges in educating Generation Z.

Urologia internationalis·2026

Related Experiment Video

Updated: Sep 24, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

549

[Urosepsis-targeted diagnostics and effective therapy].

Jennifer Kranz1,2,3, Fabian Stangl4, Christoph Kuppe5

  • 1Klinik für Urologie und Kinderurologie, Uniklinik RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland. Jennifer.Kranz@rwth-aachen.de.

Urologie (Heidelberg, Germany)
|May 6, 2022
PubMed
Summary
This summary is machine-generated.

Urosepsis, a severe urinary tract infection, arises from urogenital infections and poses significant risks, especially in healthcare settings. Prompt, multi-faceted therapy is crucial for managing this condition and its increasing prevalence.

Keywords:
AntibioticsBiomarkersBlood cultureBloodstream infectionUrinary tract infection

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
08:30

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Published on: July 9, 2012

25.6K

Related Experiment Videos

Last Updated: Sep 24, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

549
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
08:30

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Published on: July 9, 2012

25.6K

Area of Science:

  • Urology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Urinary tract infections (UTIs) present a wide clinical spectrum, from simple cystitis to life-threatening septic shock.
  • Urosepsis, originating from a urogenital source, accounts for 9-31% of septicemia cases, frequently associated with healthcare settings.
  • Obstructive uropathy, including conditions like urolithiasis and tumors, represents a primary risk factor for developing urosepsis.

Purpose of the Study:

  • To provide a comprehensive overview of urosepsis, emphasizing its clinical presentation, risk factors, and management strategies.
  • To highlight the importance of prompt and targeted therapeutic interventions for urosepsis.
  • To underscore the need for urologists to be proficient in diagnosing and treating urosepsis, anticipating its rising incidence.

Main Methods:

  • Review of clinical presentations and epidemiological data concerning UTIs and urosepsis.
  • Analysis of factors influencing disease severity, including pathogen virulence and host immune response.
  • Description of a multi-modal therapeutic approach encompassing causal, supportive, and adjunctive treatments.

Main Results:

  • Urosepsis is a severe complication of UTIs with a significant mortality risk if not managed promptly.
  • Key risk factors include obstructive uropathy and healthcare-associated infections.
  • Effective therapy involves a combination of antimicrobial treatment, source control, hemodynamic support, and potentially adjunctive therapies.

Conclusions:

  • Urosepsis requires immediate and comprehensive management, integrating antimicrobial therapy, source control, and supportive care.
  • The incidence of urosepsis is projected to increase due to demographic shifts, necessitating enhanced clinical preparedness.
  • Urologists must possess expertise in the diagnosis and effective treatment of urosepsis to improve patient outcomes.